About Eli Lilly and Company
Eli Lilly manufactures GLP-1 drugs Mounjaro and Zepbound for diabetes and obesity, driving explosive revenue growth. Beta ~0.50, tiny ~0.7% yield — trades like a growth stock with a high nominal share price. Wide premium swings around FDA events and earnings; attractive but risky for put sellers.
Pharmaceuticals — Major